SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-154524"
 

Search: id:"swepub:oai:DiVA.org:uu-154524" > Exploiting Nucleoti...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Exploiting Nucleotide Composition to Engineer Promoters

Grabherr, Manfred G. (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
Pontiller, Jens (author)
Mauceli, Evan (author)
show more...
Ernst, Wolfgang (author)
Baumann, Martina (author)
Biagi, Tara (author)
Swofford, Ross (author)
Russell, Pamela (author)
Zody, Michael C. (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
Di Palma, Federica (author)
Lindblad-Toh, Kerstin (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
Grabherr, Reingard M. (author)
show less...
 (creator_code:org_t)
2011-05-18
2011
English.
In: PLoS One. - : Public Library of Science (PLoS). - 1932-6203. ; 6:5, s. e20136-
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The choice of promoter is a critical step in optimizing the efficiency and stability of recombinant protein production in mammalian cell lines. Artificial promoters that provide stable expression across cell lines and can be designed to the desired strength constitute an alternative to the use of viral promoters. Here, we show how the nucleotide characteristics of highly active human promoters can be modelled via the genome-wide frequency distribution of short motifs: by overlapping motifs that occur infrequently in the genome, we constructed contiguous sequence that is rich in GC and CpGs, both features of known promoters, but lacking homology to real promoters. We show that snippets from this sequence, at 100 base pairs or longer, drive gene expression in vitro in a number of mammalian cells, and are thus candidates for use in protein production. We further show that expression is driven by the general transcription factors TFIIB and TFIID, both being ubiquitously present across cell types, which results in less tissue-and species-specific regulation compared to the viral promoter SV40. We lastly found that the strength of a promoter can be tuned up and down by modulating the counts of GC and CpGs in localized regions. These results constitute a "proof-of-concept" for custom-designing promoters that are suitable for biotechnological and medical applications.

Keyword

MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • PLoS One (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view